https://orcid.org/0000-0002-6328-689X
Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Qiannan Xu & Nan Xu. (2023) JAK Inhibitors as Potential Therapeutic Strategy for the Dilemma of Psoriasis Concurrent with Dermatomyositis in the SARS-CoV-2 Era. Clinical, Cosmetic and Investigational Dermatology 16, pages 1059-1062.
Read now
Read now
Colin M. Kincaid, Justin D. Arnold & Natasha A. Mesinkovska. (2023) Baricitinib as the first systemic treatment for severe alopecia areata. Expert Review of Clinical Immunology 19:6, pages 565-573.
Read now
Read now
Aishwarya Muddebihal, Ananta Khurana & Kabir Sardana. (2023) JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review. Expert Review of Clinical Pharmacology 16:4, pages 279-295.
Read now
Read now
Hassiel Aurelio Ramírez-Marín & Antonella Tosti. (2022) Emerging drugs for the treatment of alopecia areata. Expert Opinion on Emerging Drugs 27:4, pages 379-387.
Read now
Read now
F. Buket Basmanav & Regina C. Betz. (2022) Translational impact of omics studies in alopecia areata: recent advances and future perspectives. Expert Review of Clinical Immunology 18:8, pages 845-857.
Read now
Read now
Parker J. Funk, Patrick O. Perche, Rohan Singh, Katherine A. Kelly & Steven R. Feldman. (2022) Comparing available JAK inhibitors for treating patients with psoriasis. Expert Review of Clinical Immunology 18:3, pages 281-294.
Read now
Read now
Emily C. Moya, Raquel L. Bruinsma, Katherine A. Kelly & Steven R. Feldman. (2022) How suitable are JAK inhibitors in treating the inflammatory component in patients with alopecia areata and vitiligo?. Expert Review of Clinical Immunology 18:3, pages 189-191.
Read now
Read now
Articles from other publishers (20)
Eric Xia, Sara J. Li, Lara Drake, Sophia Reyes-Hadsall, Carol Mita, Aaron M. Drucker & Arash Mostaghimi. (2023) An Assessment of Current Clinician-Reported and Patient-Reported Outcome Measures for Alopecia Areata: A Scoping Review. Journal of Investigative Dermatology 143:7, pages 1133-1137.e12.
Crossref
Crossref
Michela Starace, Stephano Cedirian, Aurora M. Alessandrini, Francesca Bruni, Federico Quadrelli, Daniel F. Melo, Tatiana Silyuk, Andrei Doroshkevich, Bianca M. Piraccini & Matilde Iorizzo. (2023) Impact and Management of Loss of Eyebrows and Eyelashes. Dermatology and Therapy 13:6, pages 1243-1253.
Crossref
Crossref
Johan Mattsson, Elisabeth Israelsson, Karin Björhall, Linda Fahlén Yrlid, Kristoffer Thörn, Anna Thorén, Emelie Andersén Toledo, Lisa Jinton, Lisa Öberg, Cecilia Wingren, Sofia Tapani, Sonya G. Jackson, Gabriel Skogberg, Anders J. Lundqvist, Ramon Hendrickx, Anders Cavallin, Torben Österlund, Neil P. Grimster, Magnus Nilsson & Annika Åstrand. (2023) Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata. Skin Health and Disease 3:3.
Crossref
Crossref
Soundos Youssef, Jonathan Lavian, Eunice Y. Lee, Weijia Fan & Lindsey A. Bordone. (2023) Tofacitinib therapy for alopecia areata is not associated with adverse events during COVID-19 infection. Journal of the American Academy of Dermatology 88:5, pages 1125-1127.
Crossref
Crossref
Andrea Sechi, Junhyuk Song, Massimo Dell'Antonia, Kristine Heidemeyer, Bianca Maria Piraccini, Michela Starace & Luigi Naldi. (2023) Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review. Journal of the European Academy of Dermatology and Venereology.
Crossref
Crossref
Mohammed Muqtader Ahmed, Farhat Fatima, Aisha Alnami, Mohammad Alsenaidy, Alhussain H. Aodah, Mohammed F. Aldawsari, Bjad Almutairy, Md. Khalid Anwer & Mohammed Jafar. (2023) Design and Characterization of Baricitinib Incorporated PLA 3D Printed Pills by Fused Deposition Modeling: An Oral Pill for Treating Alopecia Areata. Polymers 15:8, pages 1825.
Crossref
Crossref
F. Buket Basmanav & Regina C. Betz. (2023) Recent advances in the genetics of alopecia areata. Medizinische Genetik 35:1, pages 15-22.
Crossref
Crossref
D. Christian FenskeYuxin DingPaula MorrowSarah G SmithMonica K SilverMeghan MoynihanJanna Manjelievskaia. (2023) Comparing the burden of illness in patients with alopecia areata vs atopic dermatitis in the US population from a payer perspective. Journal of Managed Care & Specialty Pharmacy 29:4, pages 409-419.
Crossref
Crossref
Rehito MASHIKO, Daigo OKA & Yumi AOYAMA. (2023) Effect of JAK Inhibitor on Atopic Dermatitis Patients Associated with Alopecia Areata円形脱毛症を合併したアトピー性皮膚炎症例におけるJAK 阻害薬の治療効果. The Nishinihon Journal of Dermatology 85:1, pages 34-37.
Crossref
Crossref
Sunil Dogra, Shikha Shah, Ayush Sharma, Seema Chhabra & Tarun Narang. (2023) Emerging role of baricitinib in dermatology practice: All we need to know!. Indian Dermatology Online Journal 14:2, pages 153.
Crossref
Crossref
Athanasios J. Stefanis. (2023) Janus Kinase Inhibitors in the Treatment of Alopecia Areata. Prague Medical Report 124:1, pages 5-15.
Crossref
Crossref
Yutaka SHIMOMURA, Taisuke ITO, Yoshitaka ISAKAAtsushi NISHIKAWAYumiko NISHIKAWAToshihiko ARANISHIHitoe TORISU-ITAKURAManabu OHYAMA. (2022) Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib経口 JAK 阻害薬による円形脱毛症治療：バリシチニブの治療成績を中心に. The Nishinihon Journal of Dermatology 84:6, pages 491-498.
Crossref
Crossref
Isabelle Paggioli & Jeremy Moss. (2022) Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors. Journal of Autoimmunity 133, pages 102926.
Crossref
Crossref
Sukhmani Pannu, Nathalie Ly, Zehara Abidi, Sophia Fruechte, Ronda Farah, Suleima Arruda, Neil Sadick & Maria Hordinsky. (2022) The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata. International Society of Hair Restoration Surgery 32:5, pages 153-166.
Crossref
Crossref
Ling Yu, Huiqian Yu, Shuai Zhang, Yanzhao Hao & Shoumin Zhang. (2022) Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?. Frontiers in Immunology 13.
Crossref
Crossref
Eunjin Lee, Mingyu Kim & You Jeong Lee. (2022) Selective Expansion of Tregs Using the IL-2 Cytokine Antibody Complex Does Not Reverse Established Alopecia Areata in C3H/HeJ Mice. Frontiers in Immunology 13.
Crossref
Crossref
Shahnawaz D. Jadeja & Desmond J. Tobin. (2022) Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications. Frontiers in Immunology 13.
Crossref
Crossref
Samuel J. Connell & Ali Jabbari. (2022) The current state of knowledge of the immune ecosystem in alopecia areata. Autoimmunity Reviews 21:5, pages 103061.
Crossref
Crossref
Adrienn N Bourkas & Cathryn Sibbald. (2022) Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report. SAGE Open Medical Case Reports 10, pages 2050313X2211384.
Crossref
Crossref
Masahiro Fukuyama, Taisuke Ito & Manabu Ohyama. (2021) Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines. The Journal of Dermatology 49:1, pages 19-36.
Crossref
Crossref